Rxivist logo

High throughput proteomics identifies 484 high-accuracy plasma protein biomarker signatures for ovarian cancer

By Stefan Enroth, Malin Berggrund, Maria Lycke, John Broberg, Martin Lundberg, Erika Assarsson, Matts Olovsson, Karin Stålberg, Karin Sundfeldt, Ulf Gyllensten

Posted 18 Jun 2018
bioRxiv DOI: 10.1101/349829

Ovarian cancer is usually detected at a late stage with the 5-year survival at only 30-40%. Additional means for early detection and improved diagnosis are acutely needed. To search for novel biomarkers, we compared circulating plasma levels of 981 proteins in patients with ovarian cancer and benign tumours, using the proximity extension assay. A novel combinatorial strategy was developed for identification of multivariate biomarker signatures, resulting in 484 mutually exclusive models out of which 448 did not contain the present biomarker MUCIN-16. The top-ranking model consisted of 14 proteins and had a AUC=0.95, PPV=1.0, sensitivity=0.99 and specificity=1.0 for detection of stage III-IV ovarian cancer in the discovery data, and an AUC=0.89, PPV=0.93, sensitivity=0.89 and specificity=0.95 in the replication data. The novel plasma protein signature could be used to improve the diagnosis of women with adnexal ovarian mass or in screening to identify women that should be referred to specialized examination.

Download data

  • Downloaded 464 times
  • Download rankings, all-time:
    • Site-wide: 47,594 out of 118,977
    • In cancer biology: 1,332 out of 3,767
  • Year to date:
    • Site-wide: 110,670 out of 118,977
  • Since beginning of last month:
    • Site-wide: 110,316 out of 118,977

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)